• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Pliant Therapeutics

Illustration for Fierces Chutes  Ladders feature showing a blue city skyline with executives making career moves o
Biotech

Bayer taps new chief medical officer—Chutes & Ladders

Bayer taps new chief medical officer. Cantor steps into PhRMA’s house as CEO. Moderna veteran rejoins for second act.
Darren Incorvaia , Marissa Russo , Donavyn Coffey , James Waldron Oct 2, 2026 8:30am
A doctor with a graphic representation of the lungs

Pliant ends lung disease program over rise in adverse events

Jun 30, 2025 4:49am
Winding 3D road with dollar bills

Pliant cuts workforce by 45% after bexotegrast trial safety woes

May 2, 2025 7:33am
poison pill toxic poison

Pliant, Acelyrin take ‘poison pills’ as Concentra buyout looms

Mar 14, 2025 10:01am
cancelled flights

Pliant terminates lung disease trial due to adverse events

Mar 3, 2025 11:30am
pause hold stop delay

Pliant pauses lung fibrosis trial on advice of safety committee

Feb 10, 2025 4:18am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings